About
Daniel Mukasa holds a PhD in Applied Physics and Materials Science from Caltech and completed postdoctoral work at MIT on AI and drug discovery applications. He previously worked as an AI/ML intern at Merck on antibody therapeutic design, and is now founder and CEO of AbInitio Bio.
Founder & CEO at AbInitio BioYC X26
Intro paths
YC
Daniel went through Y Combinator (Spring 2026) β any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Nicolas Dessaigne, General Partner at Y Combinator β the partner who ran AbInitio Bio's batch and knows the company first-hand. YC profile β
β
In turn, Daniel can intro founders to AbInitio Bio's investors below.
AbInitio Bio's investors Β· 1
Co-founders at AbInitio Bio
NG
Nisha GopalFounder